Manual:
Critical Access Hospital
Chapter:
Leadership LD
Topic:
COVID Testing--Reporting
How will The Joint Commission evaluate the CMS reporting requirements for SARS-CoV-2 testing?
Any examples are for illustrative purposes only.
Effective October 15, 2020, The Joint Commission is only evaluating the reporting of SARS-CoV-2 test results in the Laboratory Accreditation Program. We continue to communicate with CMS to determine the impact of these new CLIA regulations on the other accreditation programs. Joint Commission surveyors will review the documentation of SARS-CoV-2 test result reporting during the Regulatory Review session of the survey. Noncompliance with the new CLIA SARS-CoV-2 test reporting requirements will be documented at Standard LD.04.01.01, EP 2.
Please refer to the Guidance from the Department of Health and Human Services (HHS) for more information regarding additional requirements
Effective October 15, 2020, The Joint Commission is only evaluating the reporting of SARS-CoV-2 test results in the Laboratory Accreditation Program. We continue to communicate with CMS to determine the impact of these new CLIA regulations on the other accreditation programs. Joint Commission surveyors will review the documentation of SARS-CoV-2 test result reporting during the Regulatory Review session of the survey. Noncompliance with the new CLIA SARS-CoV-2 test reporting requirements will be documented at Standard LD.04.01.01, EP 2.
Please refer to the Guidance from the Department of Health and Human Services (HHS) for more information regarding additional requirements
Last updated on October 29, 2021
First Published Date: October 08, 2020